Steven W. Easley, M.D.; Decision and Order, 26515-26516 [2017-11796]
Download as PDF
Federal Register / Vol. 82, No. 108 / Wednesday, June 7, 2017 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
sradovich on DSK3GMQ082PROD with NOTICES
Steven W. Easley, M.D.; Decision and
Order
On December 29, 2016, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to Steven W. Easley,
M.D. (Registrant), of Madison,
Mississippi. The Show Cause Order
proposed the revocation of Registrant’s
Certificates of Registration, the denial of
any applications to renew or modify his
registration, and the denial of any
applications for any other DEA
registration on the ground that he lacks
‘‘state authority to handle controlled
substances’’ in Mississippi, the State in
which he is registered with the DEA.
Order to Show Cause, at 1–2 (citing 21
U.S.C. 824(a)(3)).
With respect to the Agency’s
jurisdiction, the Show Cause Order
alleged that Registrant is registered as a
practitioner in schedules II through V,
pursuant to Certificate of Registration
FE2565779, at the address of 409 Tyler
Holmes Drive, Winona, Mississippi. Id.
at 1. The Order alleged that Registrant
is also registered as a practitioner in
schedules II through V, pursuant to
Certificate of Registration No.
FE2882226, at the address of 140 BurkeCalhoun City Road, Calhoun City,
Mississippi. Id. The Order also alleged
that Registrant is registered as a
practitioner in schedules II through V,
pursuant to Certificate of Registration
No. FE2882062, at the address of 1100
Hwy 16 E, Carthage, Mississippi. Id. The
Show Cause Order alleges that all three
of these registrations expire on August
31, 2017. Id.
As substantive grounds for the
proceeding, the Show Cause Order
alleged that on March 3, 2016, the
Mississippi State Board of Medical
Licensure issued an ‘‘Order of
Prohibition, prohibiting [Registrant]
from practicing medicine,’’ that the
status of Registrant’s ‘‘Mississippi
medical license is ‘expired,’’’ and that
he is ‘‘currently without authority to
practice medicine or handle controlled
substances in the State of Mississippi,
the [S]tate in which [he is] registered
with the DEA.’’ Id. at 2. Thus, based on
his ‘‘lack of authority to [dispense]
controlled substances in . . .
Mississippi,’’ the Order asserted that
‘‘DEA must revoke’’ his registrations. Id.
(citing 21 U.S.C. 824(a)(3); 21 CFR
1301.37(b)).
The Show Cause Order notified
Registrant of his right to request a
VerDate Sep<11>2014
16:37 Jun 06, 2017
Jkt 241001
hearing on the allegations or to submit
a written statement in lieu of a hearing,
the procedure for electing either option,
and the consequence for failing to elect
either option. Id. (citing 21 CFR
1301.43). The Show Cause Order also
notified Registrant of his right to submit
a corrective action plan. Id. at 2–3.
The Government states that on
December 30, 2016, ‘‘[p]ersonnel’’ from
the Jackson District Office of the New
Orleans Field Division personally
served the Order to Show Cause on
Registrant. Government Request for
Final Agency Action (RFFA), at 1–2
(citing Exhibit (GX) 4). Registrant signed
a Form DEA–12, Receipt for Cash or
Other Items, documenting service of the
Order on him. GX 4 (stating ‘‘OTSC
Documents’’ for the ‘‘Description of
Items’’).
On March 14, 2017, the Government
forwarded its Request for Final Agency
Action and an evidentiary record to my
Office. Therein, the Government
represents that Registrant has neither
requested a hearing nor ‘‘otherwise
corresponded or communicated with
DEA regarding’’ the Show Cause Order.
RFFA, at 2. Based on the Government’s
representation and the record, I find that
more than 30 days have passed since the
Order to Show Cause was served on
Registrant, and he has neither requested
a hearing nor submitted a written
statement in lieu of a hearing. Id. at 2
(citing 21 CFR 1301.43(d)). Accordingly,
I find that Registrant has waived his
right to a hearing or to submit a written
statement and issue this Decision and
Order based on relevant evidence
submitted by the Government. I make
the following findings.
Findings of Fact
Registrant is a physician who held
Mississippi Medical License No. 15463
until it expired on March 3, 2016. GX
5. In addition, the Mississippi State
Board of Medical Licensure issued an
Order of Prohibition to Registrant on
March 3, 2016. GX 3 at 4. Under the
Order, Registrant was ‘‘immediately
prohibited from practicing medicine’’
until he undergoes a complete
evaluation for impairment at an
approved treatment facility ‘‘and
thereafter is found capable of returning
to the practice of medicine by the
Mississippi State Board of Medical
Licensure.’’ Id. Registrant has offered no
evidence that such a finding has been
made, nor that he otherwise currently
has authority to practice medicine or
dispense controlled substances under
the laws of Mississippi. Based on the
above, I find that Registrant does not
currently have authority under the laws
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
26515
of Mississippi to dispense controlled
substances.
Registrant is the holder of three DEA
Certificates of Registration, pursuant to
which he is authorized to dispense
controlled substances in schedules II
through V as a practitioner. Pursuant to
Registration No. FE2565779, Registrant
is authorized to dispense controlled
substances at the address of 409 Tyler
Holmes Drive, Winona, Mississippi. GX
1 at 1. Pursuant to Registration No.
FE2882226, Registrant is authorized to
dispense controlled substances at the
address of 140 Burke-Calhoun City
Road, Calhoun City, Mississippi. Id. at
5. Pursuant to Registration No.
FE2882062, Registrant is authorized to
dispense controlled substances at the
address of 1100 Hwy 16 E, Carthage,
Mississippi. Id. at 3. All three
registrations expire on August 31, 2017.
Id.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the
Attorney General is authorized to
suspend or revoke a registration issued
under section 823 of Title 21, ‘‘upon a
finding that the registrant . . . has had
[his] State license . . . suspended [or]
revoked . . . by competent State
authority and is no longer authorized by
State law to engage in the . . .
dispensing of controlled substances.’’
With respect to a practitioner, DEA has
long held that the possession of
authority to dispense controlled
substances under the laws of the State
in which a practitioner engages in
professional practice is a fundamental
condition for obtaining and maintaining
a registration. See, e.g., James L. Hooper,
76 FR 71371 (2011), pet. for rev. denied,
481 Fed. Appx. 826 (4th Cir. 2012); see
also Frederick Marsh Blanton, 43 FR
27616 (1978) (‘‘State authorization to
dispense or otherwise handle controlled
substances is a prerequisite to the
issuance and maintenance of a Federal
controlled substances registration.’’).
This rule derives from the text of two
provisions of the CSA. First, Congress
defined ‘‘the term ‘practitioner’ [to]
mean[ ] a . . . physician . . . or other
person licensed, registered or otherwise
permitted, by . . . the jurisdiction in
which he practices . . . to distribute,
dispense, [or] administer . . . a
controlled substance in the course of
professional practice.’’ 21 U.S.C.
802(21). Second, in setting the
requirements for obtaining a
practitioner’s registration, Congress
directed that ‘‘[t]he Attorney General
shall register practitioners . . . if the
applicant is authorized to dispense . . .
controlled substances under the laws of
the State in which [s]he practices.’’ 21
E:\FR\FM\07JNN1.SGM
07JNN1
26516
Federal Register / Vol. 82, No. 108 / Wednesday, June 7, 2017 / Notices
U.S.C. 823(f). Because Congress has
clearly mandated that a practitioner
possess state authority in order to be
deemed a practitioner under the Act,
DEA has held repeatedly that revocation
of a practitioner’s registration is the
appropriate sanction whenever he is no
longer authorized to dispense controlled
substances under the laws of the State
in which he engages in professional
practice. See, e.g., Calvin Ramsey, 76 FR
20034, 20036 (2011); Sheran Arden
Yeates, M.D., 71 FR 39130, 39131
(2006); Dominick A. Ricci, 58 FR 51104,
51105 (1993); Bobby Watts, 53 FR
11919, 11920 (1988); Blanton, 43 FR
27616 (1978).
Moreover, because ‘‘the controlling
question’’ in a proceeding brought
under 21 U.S.C. 824(a)(3) is whether the
holder of a practitioner’s registration ‘‘is
currently authorized to handle
controlled substances in the [S]tate,’’
Hooper, 76 FR at 71371 (quoting Anne
Lazar Thorn, 62 FR 12847, 12848
(1997)), the Agency has also long held
that revocation is warranted even where
a practitioner has lost his state authority
by virtue of the State’s use of summary
process and the State has yet to provide
a hearing to challenge the suspension.
Bourne Pharmacy, 72 FR 18273, 18274
(2007); Wingfield Drugs, 52 FR 27070,
27071 (1987). Thus, it is of no
consequence that the Mississippi Board
has employed summary process in
suspending Registrant’s state license.
What is consequential is that Registrant
is no longer currently authorized to
dispense controlled substances in the
State in which he is registered. I will
therefore order that his registrations be
revoked.
sradovich on DSK3GMQ082PROD with NOTICES
Order
Pursuant to the authority vested in me
by 21 U.S.C. 824(a), as well as 28 CFR
0.100(b), I order that DEA Certificates of
Registration Nos. FE2565779,
FE2882226, and FE2882062 issued to
Steven W. Easley, M.D., be, and they
hereby are, revoked. Pursuant to the
authority vested in me by 21 U.S.C.
823(f), I further order that any
applications to renew or modify the
above registrations be, and they hereby
are, denied. This Order is effective
immediately.1
Dated: May 30, 2017.
Chuck Rosenberg,
Acting Administrator.
BILLING CODE 4410–09–P
1 For the same reasons that led the Mississippi
Board to summarily suspend Registrant’s medical
license, I find that the public interest necessitates
that this Order be effective immediately. 21 CFR
1316.67.
16:37 Jun 06, 2017
Drug Enforcement Administration
[Docket No. 16–6]
Patricia A. Newton, M.D.; Order
On review of the record, I noted that
the expiration date of Respondent’s
Certificate of Registration was October
31, 2016. GX 1. I therefore took official
notice of the Agency’s registration
records for Respondent to determine if
she has filed a renewal application.
According to the Agency’s records,
Respondent had not filed a renewal
application whether timely or not.
Accordingly, on May 7, 2017, I issued
an order directing the parties to address
whether this case is now moot and
provided the parties with seven
calendar days to file their submissions.
Order, at 1 (May 7, 2017). While the
Government filed a response to my
order, Respondent has not.
In its Response, the Government
acknowledges that Respondent’s
registration has expired and states that
‘‘there is no record of any subsequent
renewal application being filed for this
registration.’’ Certification of
Registration History (May 15, 2017).
Noting that there is neither a registration
nor an application (whether timely or
not) to act upon, the Government moves
that this case be declared moot and that
the Order to Show Cause be dismissed.
Gov. Resp. to Order, at 1 (citing, inter
alia, Amy S. Benjamin, 77 FR 72408
(2012); Ronald J. Riegel, 63 FR 67132,
67133 (1998)).
There being no showing of any
collateral consequence which precludes
a finding of mootness, I grant the
Government’s motion and dismiss the
Order to Show Cause.
Dated: May 30, 2017.
Chuck Rosenberg,
Acting Administrator.
[FR Doc. 2017–11798 Filed 6–6–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 17–14]
Emmanuel O. Nwaokocha, M.D.;
Decision and Order
[FR Doc. 2017–11796 Filed 6–6–17; 8:45 am]
VerDate Sep<11>2014
DEPARTMENT OF JUSTICE
Jkt 241001
On December 5, 2016, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to Emmanuel O.
Nwaokocha, M.D. (Respondent), of
Harwood Heights, Illinois. The Show
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
Cause Order proposed the revocation of
Respondent’s DEA Certificate of
Registration No. FN5571864 on the
ground that he ‘‘do[es] not have
authority to handle controlled
substances in the State of Illinois, the
[S]tate in which [he is] registered with
the DEA.’’ Order to Show Cause, at 1
(citing 21 U.S.C. 823(f) and 824(a)(3)).
With respect to the Agency’s
jurisdiction, the Show Cause Order
alleged that Respondent is the holder of
Certificate of Registration No.
FN5571864, pursuant to which he is
authorized to dispense controlled
substances as a practitioner in schedules
II through V, at the registered address of
4740 N. Harlem Ave., Harwood Heights,
Illinois. Id. The Order also alleged that
this registration does not expire until
October 31, 2018. Id.
Regarding the substantive grounds for
the proceeding, the Show Cause Order
alleged that on March 15, 2016, the
Illinois Department of Financial and
Professional Regulation, Division of
Professional Regulation (IDFPR),
‘‘indefinitely suspended [his] license to
practice medicine due to [his]
conviction for Medicaid fraud,’’ and he
is therefore ‘‘without authority to
handle controlled substances in the
State of Illinois, the [S]tate in which [he
is] registered with the DEA.’’ Id. Based
on his ‘‘lack of authority to [dispense]
controlled substances in . . . Illinois,’’
the Order asserted that ‘‘DEA must
revoke’’ his registration. Id. at 2 (citing
21 U.S.C. 823(f) and 824(a)(3)).
The Show Cause Order notified
Respondent of (1) his right to request a
hearing on the allegations or to submit
a written statement in lieu of a hearing,
(2) the procedure for electing either
option, and (3) the consequence for
failing to elect either option. Id. (citing
21 CFR 1301.43). The Show Cause
Order also notified Respondent of his
right to submit a corrective action plan.
Id. at 2–3.
On December 13, 2016, a Diversion
Investigator from the Chicago Field
Division personally handed a copy of
the Order to Show Cause to the
Respondent at his residence located at
9453 Lorel Ave., Skokie, Illinois 60077.
Government’s Submission of Evidence
and Request for Summary Disposition
(hereinafter, Govt. Mot.), Exhibit
(hereinafter, GX) 1, at 1. Following
service of the Show Cause Order,
Respondent requested a hearing on the
allegations. The matter was placed on
the docket of the Office of
Administrative Law Judges and assigned
to Chief Administrative Law Judge John
J. Mulrooney, II (hereinafter, CALJ). On
January 4, 2017, the CALJ ordered the
Government to submit evidence to
E:\FR\FM\07JNN1.SGM
07JNN1
Agencies
[Federal Register Volume 82, Number 108 (Wednesday, June 7, 2017)]
[Notices]
[Pages 26515-26516]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11796]
[[Page 26515]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Steven W. Easley, M.D.; Decision and Order
On December 29, 2016, the Assistant Administrator, Diversion
Control Division, Drug Enforcement Administration (DEA), issued an
Order to Show Cause to Steven W. Easley, M.D. (Registrant), of Madison,
Mississippi. The Show Cause Order proposed the revocation of
Registrant's Certificates of Registration, the denial of any
applications to renew or modify his registration, and the denial of any
applications for any other DEA registration on the ground that he lacks
``state authority to handle controlled substances'' in Mississippi, the
State in which he is registered with the DEA. Order to Show Cause, at
1-2 (citing 21 U.S.C. 824(a)(3)).
With respect to the Agency's jurisdiction, the Show Cause Order
alleged that Registrant is registered as a practitioner in schedules II
through V, pursuant to Certificate of Registration FE2565779, at the
address of 409 Tyler Holmes Drive, Winona, Mississippi. Id. at 1. The
Order alleged that Registrant is also registered as a practitioner in
schedules II through V, pursuant to Certificate of Registration No.
FE2882226, at the address of 140 Burke-Calhoun City Road, Calhoun City,
Mississippi. Id. The Order also alleged that Registrant is registered
as a practitioner in schedules II through V, pursuant to Certificate of
Registration No. FE2882062, at the address of 1100 Hwy 16 E, Carthage,
Mississippi. Id. The Show Cause Order alleges that all three of these
registrations expire on August 31, 2017. Id.
As substantive grounds for the proceeding, the Show Cause Order
alleged that on March 3, 2016, the Mississippi State Board of Medical
Licensure issued an ``Order of Prohibition, prohibiting [Registrant]
from practicing medicine,'' that the status of Registrant's
``Mississippi medical license is `expired,''' and that he is
``currently without authority to practice medicine or handle controlled
substances in the State of Mississippi, the [S]tate in which [he is]
registered with the DEA.'' Id. at 2. Thus, based on his ``lack of
authority to [dispense] controlled substances in . . . Mississippi,''
the Order asserted that ``DEA must revoke'' his registrations. Id.
(citing 21 U.S.C. 824(a)(3); 21 CFR 1301.37(b)).
The Show Cause Order notified Registrant of his right to request a
hearing on the allegations or to submit a written statement in lieu of
a hearing, the procedure for electing either option, and the
consequence for failing to elect either option. Id. (citing 21 CFR
1301.43). The Show Cause Order also notified Registrant of his right to
submit a corrective action plan. Id. at 2-3.
The Government states that on December 30, 2016, ``[p]ersonnel''
from the Jackson District Office of the New Orleans Field Division
personally served the Order to Show Cause on Registrant. Government
Request for Final Agency Action (RFFA), at 1-2 (citing Exhibit (GX) 4).
Registrant signed a Form DEA-12, Receipt for Cash or Other Items,
documenting service of the Order on him. GX 4 (stating ``OTSC
Documents'' for the ``Description of Items'').
On March 14, 2017, the Government forwarded its Request for Final
Agency Action and an evidentiary record to my Office. Therein, the
Government represents that Registrant has neither requested a hearing
nor ``otherwise corresponded or communicated with DEA regarding'' the
Show Cause Order. RFFA, at 2. Based on the Government's representation
and the record, I find that more than 30 days have passed since the
Order to Show Cause was served on Registrant, and he has neither
requested a hearing nor submitted a written statement in lieu of a
hearing. Id. at 2 (citing 21 CFR 1301.43(d)). Accordingly, I find that
Registrant has waived his right to a hearing or to submit a written
statement and issue this Decision and Order based on relevant evidence
submitted by the Government. I make the following findings.
Findings of Fact
Registrant is a physician who held Mississippi Medical License No.
15463 until it expired on March 3, 2016. GX 5. In addition, the
Mississippi State Board of Medical Licensure issued an Order of
Prohibition to Registrant on March 3, 2016. GX 3 at 4. Under the Order,
Registrant was ``immediately prohibited from practicing medicine''
until he undergoes a complete evaluation for impairment at an approved
treatment facility ``and thereafter is found capable of returning to
the practice of medicine by the Mississippi State Board of Medical
Licensure.'' Id. Registrant has offered no evidence that such a finding
has been made, nor that he otherwise currently has authority to
practice medicine or dispense controlled substances under the laws of
Mississippi. Based on the above, I find that Registrant does not
currently have authority under the laws of Mississippi to dispense
controlled substances.
Registrant is the holder of three DEA Certificates of Registration,
pursuant to which he is authorized to dispense controlled substances in
schedules II through V as a practitioner. Pursuant to Registration No.
FE2565779, Registrant is authorized to dispense controlled substances
at the address of 409 Tyler Holmes Drive, Winona, Mississippi. GX 1 at
1. Pursuant to Registration No. FE2882226, Registrant is authorized to
dispense controlled substances at the address of 140 Burke-Calhoun City
Road, Calhoun City, Mississippi. Id. at 5. Pursuant to Registration No.
FE2882062, Registrant is authorized to dispense controlled substances
at the address of 1100 Hwy 16 E, Carthage, Mississippi. Id. at 3. All
three registrations expire on August 31, 2017. Id.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized
to suspend or revoke a registration issued under section 823 of Title
21, ``upon a finding that the registrant . . . has had [his] State
license . . . suspended [or] revoked . . . by competent State authority
and is no longer authorized by State law to engage in the . . .
dispensing of controlled substances.'' With respect to a practitioner,
DEA has long held that the possession of authority to dispense
controlled substances under the laws of the State in which a
practitioner engages in professional practice is a fundamental
condition for obtaining and maintaining a registration. See, e.g.,
James L. Hooper, 76 FR 71371 (2011), pet. for rev. denied, 481 Fed.
Appx. 826 (4th Cir. 2012); see also Frederick Marsh Blanton, 43 FR
27616 (1978) (``State authorization to dispense or otherwise handle
controlled substances is a prerequisite to the issuance and maintenance
of a Federal controlled substances registration.'').
This rule derives from the text of two provisions of the CSA.
First, Congress defined ``the term `practitioner' [to] mean[ ] a . . .
physician . . . or other person licensed, registered or otherwise
permitted, by . . . the jurisdiction in which he practices . . . to
distribute, dispense, [or] administer . . . a controlled substance in
the course of professional practice.'' 21 U.S.C. 802(21). Second, in
setting the requirements for obtaining a practitioner's registration,
Congress directed that ``[t]he Attorney General shall register
practitioners . . . if the applicant is authorized to dispense . . .
controlled substances under the laws of the State in which [s]he
practices.'' 21
[[Page 26516]]
U.S.C. 823(f). Because Congress has clearly mandated that a
practitioner possess state authority in order to be deemed a
practitioner under the Act, DEA has held repeatedly that revocation of
a practitioner's registration is the appropriate sanction whenever he
is no longer authorized to dispense controlled substances under the
laws of the State in which he engages in professional practice. See,
e.g., Calvin Ramsey, 76 FR 20034, 20036 (2011); Sheran Arden Yeates,
M.D., 71 FR 39130, 39131 (2006); Dominick A. Ricci, 58 FR 51104, 51105
(1993); Bobby Watts, 53 FR 11919, 11920 (1988); Blanton, 43 FR 27616
(1978).
Moreover, because ``the controlling question'' in a proceeding
brought under 21 U.S.C. 824(a)(3) is whether the holder of a
practitioner's registration ``is currently authorized to handle
controlled substances in the [S]tate,'' Hooper, 76 FR at 71371 (quoting
Anne Lazar Thorn, 62 FR 12847, 12848 (1997)), the Agency has also long
held that revocation is warranted even where a practitioner has lost
his state authority by virtue of the State's use of summary process and
the State has yet to provide a hearing to challenge the suspension.
Bourne Pharmacy, 72 FR 18273, 18274 (2007); Wingfield Drugs, 52 FR
27070, 27071 (1987). Thus, it is of no consequence that the Mississippi
Board has employed summary process in suspending Registrant's state
license. What is consequential is that Registrant is no longer
currently authorized to dispense controlled substances in the State in
which he is registered. I will therefore order that his registrations
be revoked.
Order
Pursuant to the authority vested in me by 21 U.S.C. 824(a), as well
as 28 CFR 0.100(b), I order that DEA Certificates of Registration Nos.
FE2565779, FE2882226, and FE2882062 issued to Steven W. Easley, M.D.,
be, and they hereby are, revoked. Pursuant to the authority vested in
me by 21 U.S.C. 823(f), I further order that any applications to renew
or modify the above registrations be, and they hereby are, denied. This
Order is effective immediately.\1\
---------------------------------------------------------------------------
\1\ For the same reasons that led the Mississippi Board to
summarily suspend Registrant's medical license, I find that the
public interest necessitates that this Order be effective
immediately. 21 CFR 1316.67.
Dated: May 30, 2017.
Chuck Rosenberg,
Acting Administrator.
[FR Doc. 2017-11796 Filed 6-6-17; 8:45 am]
BILLING CODE 4410-09-P